← Home / BIOAGE LABS, INC. (BIOA)
Stock Analysis
BIOAGE LABS, INC. (BIOA)
BIOA
BIOA · Market data
19.99 -2.44%
52W Range Position
84%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-06-18 13:42 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 22.92. Holding above 17.47 keeps the current thesis intact.
⚖️
Fundamentals
Strong / Negative
Price Structure
Constructive
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
17.47
Break Above
Confirmation improves above resistance.
22.92
🎯
Next Objective
Pattern-derived target if setup continues.
21.00
×
Thesis Break
Scenario weakens below invalidation.
Below 17.47
What's Driving BIOA?
📈 Technical recovery is improving
Momentum is Neutral. Watch 22.92 for confirmation and 17.47 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 17.47 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Breakout
Downtrend Break · 3 bars old · score 98
DT Break
fresh (age 3)
RSI(14)
63.5
How to read this setup
From a roadmap perspective, the setup is boxed by support near 17.47 and resistance around 21.69. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup. Pattern-based invalidation is near 14.28; losing that area would weaken the active formation considerably.
Price Chart
BIOA · WOI overlay chart
Open Full Workspace
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
Revenue Growth
Strong
Profitability
Negative
Cash Flow
Mixed
Balance Sheet
Manageable
💵 Revenue
2.77M
↗ Strong
📈 Net Income
-22.25M
↘ Negative
🧮 EPS (Basic)
-0.52
↘ Negative
BIOAGE LABS, INC.
Note: This is an algorithmic technical snapshot, not financial advice.